IOL CHEMICALS AND PHARMACEUTICALS
|
IOL CHEMICALS AND PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|---|
EQUITY AND LIABILITIES | ||||
Share Capital | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
Equity - Authorised | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr |
Equity - Issued | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
Equity Paid Up | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
Equity Shares Forfeited | - | - | - | - |
Adjustments to Equity | - | - | - | - |
Preference Capital Paid Up | - | - | - | - |
Face Value | ₹2.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - |
Total Reserves | ₹1,629 Cr | ₹1,553 Cr | ₹1,449 Cr | ₹1,334 Cr |
Securities Premium | ₹226 Cr | ₹226 Cr | ₹226 Cr | ₹226 Cr |
Capital Reserves | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
Profit & Loss Account Balance | ₹1,402 Cr | ₹1,324 Cr | ₹1,219 Cr | ₹1,104 Cr |
General Reserves | - | - | - | - |
Other Reserves | ₹-9.60 Cr | ₹-8.16 Cr | ₹-6.87 Cr | ₹-6.67 Cr |
Reserve excluding Revaluation Reserve | ₹1,629 Cr | ₹1,553 Cr | ₹1,449 Cr | ₹1,334 Cr |
Revaluation reserve | - | - | - | - |
Shareholder's Funds | ₹1,688 Cr | ₹1,612 Cr | ₹1,508 Cr | ₹1,392 Cr |
Minority Interest | - | - | - | - |
Long-Term Borrowings | - | - | - | - |
Secured Loans | - | - | - | - |
Non Convertible Debentures | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - |
Packing Credit - Bank | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - |
Term Loans - Banks | - | - | - | - |
Term Loans - Institutions | - | - | - | - |
Other Secured | - | - | - | - |
Unsecured Loans | - | - | - | - |
Fixed Deposits - Public | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - |
Loans - Banks | - | - | - | - |
Loans - Govt. | - | - | - | - |
Loans - Others | - | - | - | - |
Other Unsecured Loan | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹78 Cr | ₹66 Cr | ₹56 Cr | ₹53 Cr |
Deferred Tax Assets | ₹4.97 Cr | ₹4.56 Cr | ₹3.97 Cr | ₹2.91 Cr |
Deferred Tax Liability | ₹83 Cr | ₹71 Cr | ₹60 Cr | ₹56 Cr |
Other Long Term Liabilities | - | ₹0.04 Cr | ₹0.14 Cr | ₹0.43 Cr |
Long Term Trade Payables | - | - | - | - |
Long Term Provisions | ₹6.69 Cr | ₹6.71 Cr | ₹1.65 Cr | ₹3.01 Cr |
Total Non-Current Liabilities | ₹85 Cr | ₹73 Cr | ₹58 Cr | ₹57 Cr |
Current Liabilities | - | - | - | - |
Trade Payables | ₹428 Cr | ₹469 Cr | ₹314 Cr | ₹409 Cr |
Sundry Creditors | ₹428 Cr | ₹469 Cr | ₹314 Cr | ₹409 Cr |
Acceptances | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - |
Other Current Liabilities | ₹63 Cr | ₹55 Cr | ₹54 Cr | ₹54 Cr |
Bank Overdraft / Short term credit | - | - | - | - |
Advances received from customers | ₹8.33 Cr | ₹8.85 Cr | ₹7.44 Cr | ₹14 Cr |
Interest Accrued But Not Due | - | - | - | - |
Share Application Money | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - |
Current maturity - Others | - | - | - | - |
Other Liabilities | ₹55 Cr | ₹46 Cr | ₹47 Cr | ₹40 Cr |
Short Term Borrowings | ₹117 Cr | ₹33 Cr | ₹80 Cr | ₹43 Cr |
Secured ST Loans repayable on Demands | ₹117 Cr | ₹33 Cr | ₹80 Cr | ₹43 Cr |
Working Capital Loans- Sec | ₹117 Cr | ₹33 Cr | ₹80 Cr | ₹43 Cr |
Buyers Credits - Unsec | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - |
Other Unsecured Loans | ₹-117 Cr | ₹-33 Cr | ₹-80 Cr | ₹-43 Cr |
Short Term Provisions | ₹31 Cr | ₹40 Cr | ₹54 Cr | ₹69 Cr |
Proposed Equity Dividend | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - |
Provision for Tax | ₹29 Cr | ₹37 Cr | ₹46 Cr | ₹62 Cr |
Provision for post retirement benefits | - | - | - | - |
Preference Dividend | - | - | - | - |
Other Provisions | ₹1.97 Cr | ₹3.39 Cr | ₹8.13 Cr | ₹7.34 Cr |
Total Current Liabilities | ₹639 Cr | ₹597 Cr | ₹503 Cr | ₹575 Cr |
Total Liabilities | ₹2,411 Cr | ₹2,282 Cr | ₹2,068 Cr | ₹2,024 Cr |
ASSETS | ||||
Gross Block | ₹1,544 Cr | ₹1,236 Cr | ₹995 Cr | ₹762 Cr |
Less: Accumulated Depreciation | ₹374 Cr | ₹303 Cr | ₹243 Cr | ₹201 Cr |
Less: Impairment of Assets | - | - | - | - |
Net Block | ₹1,171 Cr | ₹933 Cr | ₹752 Cr | ₹561 Cr |
Lease Adjustment A/c | - | - | - | - |
Capital Work in Progress | ₹21 Cr | ₹100 Cr | ₹81 Cr | ₹102 Cr |
Non Current Investments | ₹17 Cr | ₹17 Cr | ₹17 Cr | - |
Long Term Investment | ₹17 Cr | ₹17 Cr | ₹17 Cr | - |
Quoted | - | - | - | - |
Unquoted | ₹17 Cr | ₹17 Cr | ₹17 Cr | - |
Long Term Loans & Advances | ₹12 Cr | ₹24 Cr | ₹9.52 Cr | ₹11 Cr |
Other Non Current Assets | ₹8.53 Cr | ₹50 Cr | ₹233 Cr | ₹205 Cr |
Total Non-Current Assets | ₹1,231 Cr | ₹1,125 Cr | ₹1,102 Cr | ₹881 Cr |
Current Assets Loans & Advances | - | - | - | - |
Currents Investments | ₹3.30 Cr | ₹2.88 Cr | ₹2.56 Cr | ₹2.37 Cr |
Quoted | - | - | - | - |
Unquoted | ₹3.30 Cr | ₹2.88 Cr | ₹2.56 Cr | ₹2.37 Cr |
Inventories | ₹361 Cr | ₹425 Cr | ₹326 Cr | ₹410 Cr |
Raw Materials | ₹168 Cr | ₹194 Cr | ₹134 Cr | ₹243 Cr |
Work-in Progress | ₹39 Cr | ₹45 Cr | ₹62 Cr | ₹60 Cr |
Finished Goods | ₹100 Cr | ₹117 Cr | ₹60 Cr | ₹48 Cr |
Packing Materials | - | - | - | - |
Stores  and Spare | ₹16 Cr | ₹21 Cr | ₹20 Cr | ₹14 Cr |
Other Inventory | ₹37 Cr | ₹48 Cr | ₹50 Cr | ₹45 Cr |
Sundry Debtors | ₹514 Cr | ₹471 Cr | ₹505 Cr | ₹470 Cr |
Debtors more than Six months | ₹8.29 Cr | ₹6.01 Cr | ₹10 Cr | ₹20 Cr |
Debtors Others | ₹508 Cr | ₹467 Cr | ₹496 Cr | ₹451 Cr |
Cash and Bank | ₹208 Cr | ₹143 Cr | ₹22 Cr | ₹140 Cr |
Cash in hand | ₹0.78 Cr | ₹0.88 Cr | ₹0.53 Cr | ₹0.42 Cr |
Balances at Bank | ₹207 Cr | ₹142 Cr | ₹21 Cr | ₹140 Cr |
Other cash and bank balances | - | - | - | - |
Other Current Assets | ₹27 Cr | ₹25 Cr | ₹30 Cr | ₹31 Cr |
Interest accrued on Investments | - | - | - | - |
Interest accrued on Debentures | - | - | - | - |
Deposits with Government | - | - | - | - |
Interest accrued and or due on loans | ₹1.65 Cr | ₹3.12 Cr | ₹0.91 Cr | ₹3.42 Cr |
Prepaid Expenses | ₹7.89 Cr | ₹13 Cr | ₹8.21 Cr | ₹7.90 Cr |
Other current_assets | ₹17 Cr | ₹8.36 Cr | ₹21 Cr | ₹20 Cr |
Short Term Loans and Advances | ₹67 Cr | ₹90 Cr | ₹82 Cr | ₹90 Cr |
Advances recoverable in cash or in kind | ₹7.40 Cr | ₹8.31 Cr | ₹9.10 Cr | ₹5.77 Cr |
Advance income tax and TDS | ₹29 Cr | ₹44 Cr | ₹48 Cr | ₹63 Cr |
Amounts due from directors | - | - | - | - |
Due From Subsidiaries | - | - | - | - |
Inter corporate deposits | - | - | - | - |
Corporate Deposits | - | - | - | - |
Other Loans & Advances | ₹31 Cr | ₹38 Cr | ₹24 Cr | ₹21 Cr |
Total Current Assets | ₹1,180 Cr | ₹1,157 Cr | ₹967 Cr | ₹1,143 Cr |
Net Current Assets (Including Current Investments) | ₹541 Cr | ₹560 Cr | ₹464 Cr | ₹567 Cr |
Miscellaneous Expenses not written off | - | - | - | - |
Total Assets | ₹2,411 Cr | ₹2,282 Cr | ₹2,068 Cr | ₹2,024 Cr |
Contingent Liabilities | ₹5.52 Cr | ₹6.08 Cr | ₹5.35 Cr | ₹0.18 Cr |
Total Debt | ₹117 Cr | ₹33 Cr | ₹80 Cr | ₹43 Cr |
Book Value | 57.49 | 274.49 | 256.81 | 237.15 |
Adjusted Book Value | 57.49 | 54.90 | 51.36 | 47.43 |
Compare Balance Sheet of peers of IOL CHEMICALS AND PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
IOL CHEMICALS AND PHARMACEUTICALS | ₹3,394.9 Cr | 3.3% | 28.2% | 14.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,124.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
IOL CHEMICALS AND PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
IOL CHEMICALS AND PHARMACEUTICALS | 3.3% |
28.2% |
14.5% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses